tiprankstipranks
Arcutis Biotherapeutics Inc (ARQT)
NASDAQ:ARQT
US Market
ARQT
Arcutis Biotherapeutics
RESEARCH TOOLSreports
Want to see ARQT full AI Analyst Report?

Arcutis Biotherapeutics (ARQT) Ratios

972 Followers

Arcutis Biotherapeutics Ratios

ARQT's free cash flow for Q1 2026 was $0.91. For the 2026 fiscal year, ARQT's free cash flow was decreased by $ and operating cash flow was $-0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.68 3.17 4.15 7.08 11.57
Quick Ratio
 2.46 2.99 3.97 6.80 11.37
Cash Ratio
 0.21 0.33 0.88 1.89 1.42
Solvency Ratio
 <0.01 -0.04 -0.72 -1.03 -1.29
Operating Cash Flow Ratio
 0.17 -0.04 -1.38 -5.29 -6.82
Short-Term Operating Cash Flow Coverage
 3.40 -5.63 0.00 0.00 -392.26
Net Current Asset Value
$ 167.70M$ 167.74M$ 144.47M$ 77.73M$ 197.71M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.01 0.32 0.60 0.45
Debt-to-Equity Ratio
 0.07 0.03 0.70 2.32 0.97
Debt-to-Capital Ratio
 0.07 0.03 0.41 0.70 0.49
Long-Term Debt-to-Capital Ratio
 0.03 0.03 0.40 0.69 0.49
Financial Leverage Ratio
 2.43 2.29 2.21 3.85 2.14
Debt Service Coverage Ratio
 0.55 0.10 -4.06 -7.76 -18.06
Interest Coverage Ratio
 0.24 -1.01 -4.73 -8.11 -19.27
Debt to Market Cap
 <0.01 <0.01 0.06 0.90 0.24
Interest Debt Per Share
 0.21 0.14 1.14 3.40 3.96
Net Debt to EBITDA
 -1.69 -14.77 -0.36 -0.52 -0.51
Profitability Margins
Gross Profit Margin
90.94%90.24%90.27%91.63%79.54%
EBIT Margin
2.36%-0.77%-57.10%-384.72%-8025.12%
EBITDA Margin
3.07%0.66%-55.78%-381.56%-7991.13%
Operating Profit Margin
0.77%-3.25%-65.33%-404.49%-8183.04%
Pretax Profit Margin
-0.33%-3.98%-70.92%-434.57%-8449.76%
Net Profit Margin
-0.57%-4.29%-71.25%-439.79%-8449.76%
Continuous Operations Profit Margin
-0.57%-4.29%-71.25%-439.79%-8449.76%
Net Income Per EBT
170.81%107.82%100.46%101.20%100.00%
EBT Per EBIT
-43.29%122.43%108.56%107.44%103.26%
Return on Assets (ROA)
-0.52%-3.73%-40.14%-76.79%-69.32%
Return on Equity (ROE)
-1.41%-8.52%-88.89%-295.65%-148.61%
Return on Capital Employed (ROCE)
1.08%-4.03%-47.93%-81.81%-73.31%
Return on Invested Capital (ROIC)
1.05%-4.02%-47.79%-81.61%-73.07%
Return on Tangible Assets
-0.53%-3.86%-41.26%-78.27%-70.45%
Earnings Yield
-0.09%-0.44%-8.31%-117.10%-38.24%
Efficiency Ratios
Receivables Turnover
 2.88 2.57 2.69 2.31 0.44
Payables Turnover
 2.06 2.93 1.35 0.42 0.09
Inventory Turnover
 1.01 1.62 1.32 0.38 0.10
Fixed Asset Turnover
 76.95 68.25 65.65 15.28 0.80
Asset Turnover
 0.90 0.87 0.56 0.17 <0.01
Working Capital Turnover Ratio
 1.49 1.40 0.73 0.17 <0.01
Cash Conversion Cycle
 311.91 242.45 141.53 241.61 201.94
Days of Sales Outstanding
 126.79 141.92 135.69 158.03 837.54
Days of Inventory Outstanding
 362.50 225.14 277.18 961.28 3.64K
Days of Payables Outstanding
 177.38 124.61 271.35 877.70 4.27K
Operating Cycle
 489.29 367.06 412.88 1.12K 4.47K
Cash Flow Ratios
Operating Cash Flow Per Share
 0.21 -0.04 -0.93 -3.56 -4.68
Free Cash Flow Per Share
 0.21 -0.05 -0.93 -3.57 -5.11
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 0.42
Free Cash Flow to Operating Cash Flow
 1.00 1.12 1.00 1.00 1.09
Dividend Paid and CapEx Coverage Ratio
 346.08 -8.20 -784.32 -577.24 -11.07
Capital Expenditure Coverage Ratio
 346.08 -8.20 -784.32 -577.24 -11.07
Operating Cash Flow Coverage Ratio
 2.04 -0.90 -1.01 -1.20 -1.27
Operating Cash Flow to Sales Ratio
 0.06 -0.01 -0.57 -4.14 -69.92
Free Cash Flow Yield
1.02%-0.17%-6.66%-110.56%-34.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.14K -228.91 -12.03 -0.85 -2.62
Price-to-Sales (P/S) Ratio
 6.32 9.82 8.57 3.76 220.96
Price-to-Book (P/B) Ratio
 14.33 19.50 10.70 2.52 3.89
Price-to-Free Cash Flow (P/FCF) Ratio
 97.64 -585.47 -15.00 -0.90 -2.90
Price-to-Operating Cash Flow Ratio
 100.69 -656.87 -15.02 -0.91 -3.16
Price-to-Earnings Growth (PEG) Ratio
 -2.33 2.58 0.17 0.03 -0.07
Price-to-Fair Value
 14.33 19.50 10.70 2.52 3.89
Enterprise Value Multiple
 204.06 1.48K -15.73 -1.50 -3.27
Enterprise Value
 2.61B 3.66B 1.72B 341.37M 963.38M
EV to EBITDA
 204.06 1.48K -15.73 -1.50 -3.27
EV to Sales
 6.27 9.73 8.77 5.73 261.36
EV to Free Cash Flow
 96.84 -579.66 -15.35 -1.38 -3.43
EV to Operating Cash Flow
 96.56 -650.35 -15.37 -1.38 -3.74
Tangible Book Value Per Share
 1.36 1.37 1.22 1.19 3.68
Shareholders’ Equity Per Share
 1.47 1.49 1.30 1.28 3.81
Tax and Other Ratios
Effective Tax Rate
 -0.71 -0.08 >-0.01 -0.01 0.00
Revenue Per Share
 3.21 2.96 1.62 0.86 0.07
Net Income Per Share
 -0.02 -0.13 -1.16 -3.78 -5.66
Tax Burden
 1.71 1.08 1.00 1.01 1.00
Interest Burden
 -0.14 5.19 1.24 1.13 1.05
Research & Development to Revenue
 0.22 0.20 0.39 1.86 49.49
SG&A to Revenue
 0.68 0.73 1.17 0.00 33.13
Stock-Based Compensation to Revenue
 0.07 0.11 0.21 0.65 8.87
Income Quality
 -11.36 0.35 0.80 0.94 0.83
Currency in USD